Related Experiment Videos
Bronchodilator and antiulcer phenoxypyrimidinones
Journal of Medicinal Chemistry
|September 1, 1980
Summary
New pyrimidinone compounds show significant bronchodilator and antiulcer activities. One compound, 5-(m-methylphenoxy)-2(1H)-pyrimidinone, demonstrated potent antiulcer effects without bronchodilator activity.
Area of Science:
- Medicinal Chemistry
- Pharmacology
Background:
- Pyrimidinone derivatives were synthesized as potential cyclic nucleotide regulators.
- Previous research identified lead compounds for further investigation.
Purpose of the Study:
- To evaluate synthesized 5-phenoxy-pyrimidinone analogues for bronchodilator and antiulcer activities.
- To identify structure-activity relationships for these pharmacological effects.
Main Methods:
- Compounds were tested for bronchodilator activity in histamine-challenged guinea pigs.
- Antiulcer activity was assessed using a cold-restraint, stressed rat ulcer model.
- Structure-activity relationships were analyzed based on substituents on the phenoxy ring.
Main Results:
- Both 2(1H)- and 4(3H)-pyrimidinone series exhibited bronchodilator activity comparable to or exceeding theophylline.
- Bronchodilator activity was enhanced by para-substituents on the phenoxy ring.
- Significant antiulcer activity was observed in the 2(1H)-pyrimidinone series, with one analogue outperforming carbenoxolone without bronchodilator effects.
Conclusions:
- Pyrimidinone derivatives represent a promising class of compounds for developing novel bronchodilator and antiulcer agents.
- 5-(m-methylphenoxy)-2(1H)-pyrimidinone is a potent antiulcer agent with a distinct pharmacological profile.
- Further research into these pyrimidinone analogues could lead to new therapeutic strategies.